Albemarle (NYSE:ALB – Free Report) had its price target lowered by UBS Group from $86.00 to $64.00 in a research report released on Monday,Benzinga reports. The brokerage currently has a neutral ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果一些您可能无法访问的结果已被隐去。
显示无法访问的结果